|
PARP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.23809999977398E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.14179999999953E-05 |
| Normal-vs-Stage2 |
5.457400E-03 |
| Normal-vs-Stage3 |
2.0303000003441E-07 |
| Normal-vs-Stage4 |
1.310330E-02 |
| Stage1-vs-Stage2 |
9.024400E-01 |
| Stage1-vs-Stage3 |
1.267790E-01 |
| Stage1-vs-Stage4 |
6.155000E-01 |
| Stage2-vs-Stage3 |
3.336400E-01 |
| Stage2-vs-Stage4 |
6.410800E-01 |
| Stage3-vs-Stage4 |
1.002600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.69079999579847E-08 |
| Normal-vs-AfricanAmerican |
1.552620E-01 |
| Normal-vs-Asian |
2.756000E-01 |
| Caucasian-vs-AfricanAmerican |
6.133600E-01 |
| Caucasian-vs-Asian |
9.170000E-01 |
| AfricanAmerican-vs-Asian |
8.938600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.64789995380244E-09 |
| Normal-vs-Female |
9.201400E-03 |
| Male-vs-Female |
2.267600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.480800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.21980000048028E-07 |
| Normal-vs-Age(61-80Yrs) |
4.17420000000668E-05 |
| Normal-vs-Age(81-100Yrs) |
4.071900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.666800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.890200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.373800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.829200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.705600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.658600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.485600E-01 |
| Normal-vs-Grade 2 |
3.92910000091007E-08 |
| Normal-vs-Grade 3 |
3.60719999999981E-05 |
| Normal-vs-Grade 4 |
8.907600E-02 |
| Grade 1-vs-Grade 2 |
1.387760E-01 |
| Grade 1-vs-Grade 3 |
3.640400E-01 |
| Grade 1-vs-Grade 4 |
7.853800E-01 |
| Grade 2-vs-Grade 3 |
6.804000E-01 |
| Grade 2-vs-Grade 4 |
8.738000E-02 |
| Grade 3-vs-Grade 4 |
1.942810E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.23800000543184E-08 |
| Normal-vs-ccB subtype |
2.620800E-04 |
| ccA subtype-vs-ccB subtype |
3.552000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.36389999960684E-07 |
| Normal-vs-N1 |
4.941000E-01 |
| N0-vs-N1 |
5.342000E-02 |
|
|
